Editor's Review

By OMBOKI MONAYO Sharp reactions have greeted American government’s decision to withdraw the Centres for Disease Control (CDC) research papers pending review. Experts say the directive will have significant implications for public health research, particularly in the context of long-term effects on scientific integrity, funding, and global health communication. Also Read Tusker Backs Prinsloo Sevens […]

CDC headquarters in Atlanta, Georgia, USA. Image/ Courtesy, Shutterstock.

By OMBOKI MONAYO

Sharp reactions have greeted American government’s decision to withdraw the Centres for Disease Control (CDC) research papers pending review.

Experts say the directive will have significant implications for public health research, particularly in the context of long-term effects on scientific integrity, funding, and global health communication.

In Kenya, the CDC conducts research primarily focused on areas like HIV/AIDS, tuberculosis, malaria, immunization, influenza, migration health, and overall health systems strengthening.

CDC leverages a long-standing presence in the country to build upon existing surveillance and laboratory platforms for disease detection and control.

CDC provides support to the Kenya National Public Health Laboratory (NPHL) in Nairobi on diagnostics, outbreak detection and systems development.

Several laboratory programs such as HIV and TB drug resistance testing, and the National Influenza Center operate through CDC support.

Notably, the organization’s work in Kenya includes research related to COVID-19 surveillance.

This writer made an attempt to sample the potential impacts in detail of Donald Trump’s administration.

Reacting to the directive, Dr. Alfredo Morabia, who is the Editor-in-Chief of the American Journal of Public Health said, “It sounds incredible that this is compatible with the First Amendment.”

“A constitutional right has been canceled. How can the government decide what words a journal can use to describe a scientific reality? That reality needs to be named,” he said.

The concerns

One of the most immediate concerns stemming from this directive is the erosion of scientific integrity.

By imposing political constraints on what can be published, the administration risks creating an environment where scientific findings are manipulated to align with political agendas rather than being based on empirical evidence.

The move is particularly alarming in public health, where accurate data is crucial for informing policy and practice.

Public health research often addresses sensitive issues that require nuanced language and a comprehensive understanding of diverse populations.

The directive’s focus on removing terms related to gender and sexual identity could hinder researchers’ ability to accurately discuss and address health disparities faced by marginalized groups, including those affected by HIV/AIDS and other sexually transmitted infections.

According to Carl Schmid, Executive Director of the HIV+ Hepatitis Policy Institute, the directive seeks to disenfranchise vulnerable key populations by dismissing their importance or diminishing their existence in efforts to eradicate infectious diseases.

“We can’t just erase or ignore certain populations when it comes to preventing, treating or researching infectious diseases such as HIV.

I certainly hope this is not the intent of these orders,” he noted.

This could lead to a lack of targeted interventions for populations that are already vulnerable, ultimately worsening health inequalities.

CDC personnel discuss the findings of surveillance data obtained from a malaria research project in Kenya. President Donald Trump’s directive on the suspension of research publications could seriously hamper such initiatives in the future. Image/ Courtesy, CDC

Disruption of Research Funding

The directive also has the potential to disrupt the funding landscape for public health research.

As noted in prior reports, government funding is a critical lifeline for many research initiatives in many low and middle income countries including Kenya.

The uncertainty created by this directive may deter researchers from applying for grants or pursuing projects that could contribute valuable insights into public health challenges.

When federal agencies like the NIH face administrative freezes or delays in grant review processes, it can lead to cash flow challenges for research groups.

Early-career scientists, who often rely on timely funding to establish their labs and conduct meaningful research, may find themselves particularly vulnerable.

This disruption can stifle innovation and slow progress in addressing pressing public health issues.

Global Health Communication

The implications of this directive extend beyond U.S. borders, affecting global health communication efforts.

African countries like Kenya, which often rely on collaboration with U.S.-based researchers and institutions, may find their own public health initiatives hampered by the withdrawal of critical research findings.

The lack of accessible data can hinder local journalists’ ability to report accurately on health issues, leading to misinformation and a lack of awareness about pressing public health concerns.

Dr. Carlos Del Rio, Chief Section Editor for HIV/AIDS for NEJM Journal Watch Infectious Diseases, termed the directive a negative development in the field of global health communications.

“This is a travesty. CDC scientists publish every year important work that informs the field of public health. Stopping publications is never good,” he pointed out.

Moreover, the directive may strain international collaborations that are essential for tackling global health challenges.

If U.S.-based researchers are compelled to withdraw their names from studies or alter their findings due to political pressure, it could discourage collaboration with African partners who rely on U.S. expertise and funding.

A CDC scientist analyzes COVID-19 test samples in a Kenyan laboratory. President Donald Trump’s recent directive to the CDC poses a significant threat to similar research efforts in countries like Kenya where scientists collaborate with their US counterparts to carry out studies on infectious diseases and publish research findings. Image/ Courtesy, CDC

Long-Term Consequences for Public Health Policy

In the long run, the political interference in scientific publishing can have dire consequences for public health policy.

Policymakers depend on robust scientific evidence to craft effective health policies and interventions.

If the integrity of research is compromised, it could lead to poorly informed policies that fail to address the needs of diverse populations.

Dr Jane Liebschutz, who is an Opioid Addiction Researcher at the University of Pittsburgh, identified the directive’s potential to adversely impact the current research efforts in various critical areas.

“This kind of disruption could have long ripple effects. Even short delays will put the United States behind in research,” Dr Liebschutz stated.

Furthermore, as seen during previous administrations, abrupt changes in public health policy can create confusion and mistrust among both researchers and the general public.

A lack of transparency regarding how decisions are made can erode trust in public health institutions, making it more challenging to implement effective public health measures during crises.

Advocacy for Scientific Freedom

In light of these potential long-term effects, it is crucial for advocates within the scientific community to stand firm against political interference in research.

Journal editors and researchers must work collaboratively to uphold academic freedom and ensure that scientific inquiry remains free from external pressures.

Advocacy efforts should focus on promoting transparency in public health communications while emphasizing the importance of protecting marginalized populations in research discussions.

By fostering an environment where diverse voices are heard and respected, the scientific community can better address complex public health challenges.

What Lies Ahead

The Trump administration’s directive to the CDC research papers poses significant risks to the integrity of public health research both domestically and globally.

The potential long-term effects include erosion of scientific integrity, disruption of funding streams, negative impacts on global health communication, and poorly informed public health policies.

A National Institutes of Health (NIH) scientist who wished to remain anonymous highlighted the general sense of uncertainty pervading the scientific community as a result of the directive.

“People are just at a loss because they also don’t know what’s coming next. I have never seen this level of confusion and concern in people that are extremely dedicated to their mission,” said the researcher.

As we navigate these challenges, it is imperative for researchers, journalists, and advocates to unite in defending the principles of scientific inquiry and ensuring that evidence-based practices remain at the forefront of public health initiatives.

Only through cross-border, multi-institutional collaboration and commitment to transparency can we hope to address the complex health challenges facing populations worldwide effectively.